Siaw, J. T., Wan, H., Pfeifer, K., Rivera, V. M., Guan, J., Palmer, R. H., & Hallberg, B. (2016). Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice. Oncotarget.

Siaw, Joachim T., Haiying Wan, Kathrin Pfeifer, Victor M. Rivera, Jikui Guan, Ruth H. Palmer, و Bengt Hallberg. "Brigatinib, an Anaplastic Lymphoma Kinase Inhibitor, Abrogates Activity and Growth in ALK-positive Neuroblastoma Cells, Drosophila and Mice." Oncotarget 2016.

Siaw, Joachim T., et al. "Brigatinib, an Anaplastic Lymphoma Kinase Inhibitor, Abrogates Activity and Growth in ALK-positive Neuroblastoma Cells, Drosophila and Mice." Oncotarget 2016.